NewEdge Advisors’s Mustang Bio MBIO Stock Holding History

NewEdge Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3	Closed	-$138	–	3918
2024 Q1	$138	Hold	3	–	–	﹤0.01%	3692
2023 Q4	$184	Hold	3	–	–	﹤0.01%	3610
2023 Q3	$281	Hold	3	–	–	﹤0.01%	3298
2023 Q2	$845	Hold	3	–	–	﹤0.01%	3270
2023 Q1	$751	Hold	3	–	–	﹤0.01%	3194
2022 Q4	$1	Buy	+3	New	+$1.02K	﹤0.01%	4022

Other funds holding MBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFS

Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

NewEdge Advisors's MBIO Position: Q2 2024 in Review

NewEdge Advisors sold out of Mustang Bio (MBIO) in Q2 2024, closing a stake of 3 shares — an estimated $138 sold.

NewEdge Advisors first reported a position in MBIO in Q4 2022 and held it in 6 quarters. The position peaked at $845 in Q2 2023. 28 funds tracked by Wall St. Rank hold MBIO as of Q2 2024.

NewEdge Advisors reported no remaining Mustang Bio position as of Q2 2024 after selling out during the quarter.
NewEdge Advisors sold 3 Mustang Bio shares in Q2 2024, an estimated $138.
NewEdge Advisors first reported a position in Mustang Bio in Q4 2022 and held it in 6 quarters.
NewEdge Advisors's Mustang Bio position peaked at $845 in Q2 2023.
28 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2024.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.